Home » Topics » BioWorld

BioWorld
RSS

ENZON GETS RIGHTS TO GAUCHER'S DRUG

Oct. 19, 1992

BIOCRYST FILES ANOTHER IND FOR BCX-34

Oct. 19, 1992

USDA DEREGULATES CALGENE TOMATO

Oct. 19, 1992

ALPHA-BETA RETURNS TO IPO MARKET FOR $16M

Oct. 19, 1992

APPLIED IMMUNE MOVES TO LARGER FACILITY

Oct. 19, 1992

GENELABS GRANTS CO-MARKETING RIGHTS

Oct. 19, 1992

AMGEN NAMES PRESIDENT

Oct. 19, 1992

NAS URGES LARGER FEDERAL ROLE IN VACCINES

Oct. 16, 1992

LTI'S LIPID-COMPLEXED DRUG LESS TOXIC

Oct. 16, 1992

STOCKS CONTINUE TO RISE

Oct. 16, 1992

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...